Librando, Elyn .

HRN: 20-62-45  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/12/2024
CO-AMOXICLAV 625MG (TAB)
11/12/2024
11/19/2024
ORAL
625mg
3x A Day
S/p NSVD
Waiting Final Action 
11/12/2024
CEFUROXIME 500MG (TAB)
11/12/2024
11/19/2024
PO
500mg
BID
S/P Nsvd Non-institutional Delivery
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: